Advertisement

Is Eli Lilly Stock A Sell On A Rare Stumble In Obesity Treatment?

Is Eli Lilly Stock A Sell On A Rare Stumble In Obesity Treatment?

Is Eli Lilly stock a buy after shares have leveraged a comeback following the acquisition of Morphic and positive weight-loss drug news?